Dr. Walsh Compares Open and Robotic-Assisted Radical Prostatectomy Operations

Video

In Partnership With:

Patrick C. Walsh, MD, university distinguished service professor of urology, Johns Hopkins School of Medicine, discusses radical prostatectomy operations in the traditional open and robotic-assisted form.

Patrick C. Walsh, MD, university distinguished service professor of urology, Johns Hopkins School of Medicine, discusses radical prostatectomy operations in the traditional open and robotic-assisted form.

Both operations' procedures require knowing the locations of the sphincter, venous drainage, nerves, and fascial structure that covers the prostate. Walsh, who has vast experience performing open prostatectomies, says the standard procedure can be difficult and requires a significant amount of training.

Mani Menon, MD, from the Henry Ford Vattikuti Urology Institute, pioneered robotic prostatectomy after having difficulties with the laparoscopic procedure.

At Johns Hopkins School of Medicine, approximately 60% of patients choose robotic prostatectomy, and 40% choose the open operation. Walsh adds there is no evidence that suggests robotic prostatectomy is more effective than its open counterpart. However, it has allowed doctors to perform prostatectomies who could not do so laparoscopically, due to increased intraabdominal pressure and blood loss.

Related Videos
Sarah E. S. Leary, MD, MS, attending physician, medical director, Pediatric Brain Tumor Program, Seattle Children’s Hospital; professor, Department of Pediatrics, University of Washington School of Medicine
Rita Nanda, MD
Vikram Narayan, MD
Daniel Olson, MD
Vishal Patel, MD, FAAD, FACMS, associate professor, Dermatology, George Washington (GW) School of Medicine & Health Sciences
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Jorge J. Castillo, MD,
Heinz-Josef Lenz, MD, FACP
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute